comprehensive -WSS

comprehensive

author：fashion 2025-09-29 21:26:47 - browse：7387

Brain cancer — Michelle Monje/Stanford University/NIH

Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

“We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Experimental asthma app from Apple and Anthem shows promise

Wikipedia

focus

WSS

Why workplace violence is so common in health care

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Ventyx halts psoriasis drug development after lackluster trial results

The UK government moves asylum

Moderna hits safety problems in bold bid to reinvent medicine

Study suggests Covid rebound is far more common with Paxlovid than without

hotspot

comprehensive

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

NIH chief: government has fallen behind pharma on clinical trials

Cancer drug shortages should be causing more outrage

White House drug czar issues call for 'recovery

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

What health policies could hitch a ride on a spending bill?

Walensky prepares to leave CDC — and Congress — behind

Study suggests Covid rebound is far more common with Paxlovid than without

focus

Mississippi candidates for statewide offices square off in party primaries

FDA reorg will put new emphasis on investigations, sources say

At least 12 people were injured in a blast at a port in northwest Turkey

What health policies could hitch a ride on a spending bill?

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Wikipedia

Wikipedia

focus

hotspot